Jeanelle
M.
Spencer,
PhD
St.
NE
#2,
Washington
DC
20017
6621
•
************@*****.***
Analytical
scientist
committed
to
identifying
and
relating
scientific
discovery
for
clinical
utilization
Scientific
leader
broad
scientific
knowledge
base
with
demonstrated
influence
in
clinical
and
academic
environments
Excellent
communicator
superior
ability
to
convey
complex
material
to
expert
and
non
expert
audiences
using
written,
verbal,
and
digital
methods
Team
Leader
successfully develop
and
maintain
professional
relationships
to
foster
collaboration
and
disseminate
information
Education
PhD
Johns
Hopkins
School
of
Medicine,
Biochemistry,
Cellular
and
Molecular
Biology
Program,
Baltimore,
MD
2011
BS
Howard
University,
Department
of
Chemistry,
Washington,
DC
2003
Work
Experience
The
Center
for
Advancing
Innovation,
Leesburg,
VA
Technology
Assessment
and
Market
Planning
2013
present
Strategy
Consulting
Intern
National
Cancer
Institute
portfolio
analysis
to
find
partners
and
commercialize
inventions
• Scientific
Expert
Evaluate
scientific
inventions/patents
for
commercial
viability;
identify
the
useful
market
for
such
inventions;
deliver
disease
education
• Resource
Developer
Identify
potential
partners
and
investigators
for
product
execution,
cultivate
many
relationships
from
peer
to
peer
and
leadership
perspectives
National
Institute
of
Health
Fellows’
Committee,
Bethesda,
MD
Human
Research
Protections
Program
2013
present
Human
Subjects
Research
Advisory
Committee
Liaison
Serve
as
a
resource
to
the
Fellows’
community
• Patient
Advocacy
and
Clinical
Trial
Ethics
participate
in
discussions
to
ensure
safety
of
the
patient
and
ethical
clinical
trial
protocols;
serve
as
an
advocate
in
committee
meetings
• Advisory
Representative
act
as
a
go
between
for
the
Advisory
Committee
and
Fellows’
Committee;
report
any
relevant
issues;
review
investigator
initiated
protocols
National
Cancer
Institute,
NIH,
Bethesda,
MD
Molecular
Oncology
and
Gene
Transfer
Section
2011
present
Postdoctoral
Research
Fellow
Investigate
GATA2
in
hematopoiesis
and
cancer
• Translational
Research
Develop
gene
therapy
strategies
for
rare
immunodeficiencies
using
lentiviral
vectors;
plan,
conduct
and
report
research
related
to
gene
therapy
and
hematopoietic
stem
cell
treatments
• Recognized
Expert
Present
data
at
conferences,
symposiums
and
professional
society
meetings;
develop
relationships
with
clinicians
at
departmental
seminars
and
colloquia;
contribute
to
collaborative
research
teams;
won
Keystone
Society
Future
of
Science
Award;
communicate
insights
on
advances
in
gene
therapy
therapeutics
• Clinical
Study
Involvement
Translate
basic
research
findings
into
high
quality
medial
dialogue;
deliver
presentations
to
clinicians
and
advise
principal
investigators
protocols;
train
and
supervise
junior
scientists
Key
Presentations
Keystone
Symposia:
Hematopoiesis
2013
•
Mid
Atlantic
Transposition
Meeting
2010
•
American
Society
for
Biochemistry
and
Molecular
Biology
Annual
Meeting
2010
•
Areas
of
Expertise
Molecular
Biology
•
Oncology
•
Gene
Therapy
•
Hematology
•
Hematopoietic
Stem
Cells
•